ID   NMDE2_RAT               Reviewed;        1482 AA.
AC   Q00960; Q62684;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   02-OCT-2024, entry version 212.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2B;
DE            Short=GluN2B;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-2;
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2B;
DE            Short=NMDAR2B;
DE            Short=NR2B {ECO:0000303|PubMed:1350383};
DE   Flags: Precursor;
GN   Name=Grin2b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RC   TISSUE=Brain;
RX   PubMed=1350383; DOI=10.1126/science.256.5060.1217;
RA   Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H.,
RA   Burnashev N., Sakmann B., Seeburg P.H.;
RT   "Heteromeric NMDA receptors: molecular and functional distinction of
RT   subtypes.";
RL   Science 256:1217-1221(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7524561; DOI=10.1016/0896-6273(94)90258-5;
RA   Sullivan J.M., Traynelis S.F., Chen H.S., Escobar W., Heinemann S.F.,
RA   Lipton S.A.;
RT   "Identification of two cysteine residues that are required for redox
RT   modulation of the NMDA subtype of glutamate receptor.";
RL   Neuron 13:929-936(1994).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE, PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=7513428; DOI=10.1073/pnas.91.9.3954;
RA   Moon I.S., Apperson M.L., Kennedy M.B.;
RT   "The major tyrosine-phosphorylated protein in the postsynaptic density
RT   fraction is N-methyl-D-aspartate receptor subunit 2B.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3954-3958(1994).
RN   [4]
RP   INTERACTION WITH DLG4.
RX   PubMed=7569905; DOI=10.1126/science.7569905;
RA   Kornau H.C., Schenker L.T., Kennedy M.B., Seeburg P.H.;
RT   "Domain interaction between NMDA receptor subunits and the postsynaptic
RT   density protein PSD-95.";
RL   Science 269:1737-1740(1995).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9509416;
RA   Jin D.H., Jung Y.W., Ko B.H., Moon I.S.;
RT   "Immunoblot analyses on the differential distribution of NR2A and NR2B
RT   subunits in the adult rat brain.";
RL   Mol. Cells 7:749-754(1997).
RN   [6]
RP   INTERACTION WITH PATJ.
RX   PubMed=9647694; DOI=10.1006/mcne.1998.0679;
RA   Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J.;
RT   "CIPP, a novel multivalent PDZ domain protein, selectively interacts with
RT   Kir4.0 family members, NMDA receptor subunits, neurexins, and
RT   neuroligins.";
RL   Mol. Cell. Neurosci. 11:161-172(1998).
RN   [7]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1; GRIN3A AND PPP2CB.
RX   PubMed=11588171; DOI=10.1523/jneurosci.21-20-07985.2001;
RA   Chan S.F., Sucher N.J.;
RT   "An NMDA receptor signaling complex with protein phosphatase 2A.";
RL   J. Neurosci. 21:7985-7992(2001).
RN   [8]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=11160393; DOI=10.1523/jneurosci.21-04-01228.2001;
RA   Perez-Otano I., Schulteis C.T., Contractor A., Lipton S.A., Trimmer J.S.,
RA   Sucher N.J., Heinemann S.F.;
RT   "Assembly with the NR1 subunit is required for surface expression of NR3A-
RT   containing NMDA receptors.";
RL   J. Neurosci. 21:1228-1237(2001).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=12391275; DOI=10.1124/mol.62.5.1119;
RA   Al-Hallaq R.A., Jarabek B.R., Fu Z., Vicini S., Wolfe B.B., Yasuda R.P.;
RT   "Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2
RT   subunits.";
RL   Mol. Pharmacol. 62:1119-1127(2002).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND GRIN3A.
RX   PubMed=11929923; DOI=10.1152/jn.00531.2001;
RA   Sasaki Y.F., Rothe T., Premkumar L.S., Das S., Cui J., Talantova M.V.,
RA   Wong H.-K., Gong X., Chan S.F., Zhang D., Nakanishi N., Sucher N.J.,
RA   Lipton S.A.;
RT   "Characterization and comparison of the NR3A subunit of the NMDA receptor
RT   in recombinant systems and primary cortical neurons.";
RL   J. Neurophysiol. 87:2052-2063(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-882; SER-886; SER-917;
RP   SER-920; TYR-1039; SER-1255; SER-1259 AND SER-1303, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=22960932; DOI=10.1038/nn.3214;
RA   Rodenas-Ruano A., Chavez A.E., Cossio M.J., Castillo P.E., Zukin R.S.;
RT   "REST-dependent epigenetic remodeling promotes the developmental switch in
RT   synaptic NMDA receptors.";
RL   Nat. Neurosci. 15:1382-1390(2012).
RN   [13]
RP   IDENTIFICATION IN A COMPLEX WITH GRIN1 AND PRR7, AND INTERACTION WITH PRR7.
RX   PubMed=27458189; DOI=10.15252/embj.201593070;
RA   Kravchick D.O., Karpova A., Hrdinka M., Lopez-Rojas J., Iacobas S.,
RA   Carbonell A.U., Iacobas D.A., Kreutz M.R., Jordan B.A.;
RT   "Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates
RT   NMDA-mediated excitotoxicity.";
RL   EMBO J. 35:1923-1934(2016).
RN   [14]
RP   INTERACTION WITH DLG3 AND DLG4, AND MUTAGENESIS OF SER-1413; LEU-1422 AND
RP   SER-1450.
RX   PubMed=28283559; DOI=10.1523/jneurosci.0827-16.2017;
RA   Liu S., Zhou L., Yuan H., Vieira M., Sanz-Clemente A., Badger J.D. II,
RA   Lu W., Traynelis S.F., Roche K.W.;
RT   "A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with
RT   Autism Affects NMDA Receptor Surface Expression and Spine Density.";
RL   J. Neurosci. 37:4093-4102(2017).
RN   [15]
RP   INTERACTION WITH ARC.
RX   PubMed=31080121; DOI=10.1016/j.str.2019.04.001;
RA   Nielsen L.D., Pedersen C.P., Erlendsson S., Teilum K.;
RT   "The capsid domain of Arc changes its oligomerization propensity through
RT   direct interaction with the NMDA receptor.";
RL   Structure 0:0-0(2019).
RN   [16] {ECO:0007744|PDB:3JPW, ECO:0007744|PDB:3JPY}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 32-394, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, ACTIVITY REGULATION, GLYCOSYLATION AT ASN-74 AND
RP   ASN-341, MUTAGENESIS OF HIS-60; HIS-127; ASP-283; GLU-284; HIS-311 AND
RP   HIS-359, AND DISULFIDE BOND.
RX   PubMed=19910922; DOI=10.1038/emboj.2009.338;
RA   Karakas E., Simorowski N., Furukawa H.;
RT   "Structure of the zinc-bound amino-terminal domain of the NMDA receptor
RT   NR2B subunit.";
RL   EMBO J. 28:3910-3920(2009).
RN   [17] {ECO:0007744|PDB:3QEL, ECO:0007744|PDB:3QEM}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 31-394, FUNCTION, SUBCELLULAR
RP   LOCATION, SUBUNIT, ACTIVITY REGULATION, GLYCOSYLATION AT ASN-74 AND
RP   ASN-341, AND DISULFIDE BONDS.
RX   PubMed=21677647; DOI=10.1038/nature10180;
RA   Karakas E., Simorowski N., Furukawa H.;
RT   "Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA
RT   receptors.";
RL   Nature 475:249-253(2011).
RN   [18] {ECO:0007744|PDB:4PE5}
RP   X-RAY CRYSTALLOGRAPHY (3.96 ANGSTROMS) OF 27-852 IN COMPLEX WITH GRIN1 AND
RP   GLUTAMATE, FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT, GLYCOSYLATION
RP   AT ASN-74; ASN-341 AND ASN-688, AND DISULFIDE BONDS.
RX   PubMed=24876489; DOI=10.1126/science.1251915;
RA   Karakas E., Furukawa H.;
RT   "Crystal structure of a heterotetrameric NMDA receptor ion channel.";
RL   Science 344:992-997(2014).
RN   [19] {ECO:0007744|PDB:5B3J, ECO:0007744|PDB:5FXG, ECO:0007744|PDB:5FXH, ECO:0007744|PDB:5FXI, ECO:0007744|PDB:5FXJ, ECO:0007744|PDB:5FXK}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 31-394, STRUCTURE BY ELECTRON
RP   MICROSCOPY (6.1 ANGSTROMS) OF 27-852 IN COMPLEX WITH GRIN1, FUNCTION,
RP   SUBCELLULAR LOCATION, SUBUNIT, TOPOLOGY, AND DISULFIDE BONDS.
RX   PubMed=27135925; DOI=10.1038/nature17679;
RA   Tajima N., Karakas E., Grant T., Simorowski N., Diaz-Avalos R.,
RA   Grigorieff N., Furukawa H.;
RT   "Activation of NMDA receptors and the mechanism of inhibition by
RT   ifenprodil.";
RL   Nature 534:63-68(2016).
RN   [20] {ECO:0007744|PDB:5TPZ}
RP   X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 32-393 IN COMPLEX WITH GRIN1,
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, GLYCOSYLATION AT ASN-341, AND
RP   DISULFIDE BONDS.
RX   PubMed=27916457; DOI=10.1016/j.neuron.2016.11.006;
RA   Romero-Hernandez A., Simorowski N., Karakas E., Furukawa H.;
RT   "Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition
RT   in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.";
RL   Neuron 92:1324-1336(2016).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium. Channel
CC       activation requires binding of the neurotransmitter glutamate to the
CC       epsilon subunit, glycine binding to the zeta subunit, plus membrane
CC       depolarization to eliminate channel inhibition by Mg(2+)
CC       (PubMed:1350383, PubMed:19910922, PubMed:21677647, PubMed:24876489,
CC       PubMed:27135925, PubMed:27916457). Sensitivity to glutamate and channel
CC       kinetics depend on the subunit composition (Probable). In concert with
CC       DAPK1 at extrasynaptic sites, acts as a central mediator for stroke
CC       damage. Its phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA
CC       receptor channel activity inducing injurious Ca2+ influx through them,
CC       resulting in an irreversible neuronal death. Contributes to neural
CC       pattern formation in the developing brain. Plays a role in long-term
CC       depression (LTD) of hippocampus membrane currents and in synaptic
CC       plasticity (By similarity). {ECO:0000250|UniProtKB:Q01097,
CC       ECO:0000269|PubMed:1350383, ECO:0000269|PubMed:19910922,
CC       ECO:0000269|PubMed:21677647, ECO:0000269|PubMed:24876489,
CC       ECO:0000269|PubMed:27135925, ECO:0000269|PubMed:27916457, ECO:0000305}.
CC   -!- ACTIVITY REGULATION: Channel activity is inhibited by micromolar levels
CC       of zinc ions (PubMed:19910922). Channel activity is inhibited by
CC       ifenprodil (PubMed:19910922, PubMed:21677647).
CC       {ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed of
CC       two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B,
CC       GRIN2C or GRIN2D) (in vitro) (PubMed:1350383, PubMed:19910922,
CC       PubMed:21677647, PubMed:24876489, PubMed:27135925, PubMed:27916457).
CC       Can also form heterotetrameric channels that contain at least one zeta
CC       subunit (GRIN1), at least one epsilon subunit, plus GRIN3A or GRIN3B.
CC       In vivo, the subunit composition may depend on the expression levels of
CC       the different subunits. Found in a complex with GRIN1, GRIN3A and
CC       PPP2CB. Found in a complex with GRIN1 and GRIN3B. Interacts with MAGI3.
CC       Interacts with HIP1 and NETO1. Interacts with PDZ domains of PATJ, DLG3
CC       and DLG4. Interacts with DAPK1 (By similarity). Found in a complex with
CC       GRIN1 and PRR7 (PubMed:27458189). Interacts with PRR7
CC       (PubMed:27458189). Interacts with CAMK2A (By similarity). Interacts
CC       with ARC; preventing ARC oligomerization (PubMed:31080121). Interacts
CC       with TMEM25 (By similarity). Interacts (via the extreme C-terminus)
CC       with FRMPD2 (via the second PDZ domain); the interaction is direct and
CC       is likely to promote NMDAR-mediated neural signal transmission (By
CC       similarity). Interacts with FAM81A; the interaction facilitates
CC       condensate formation via liquid-liquid phase separation (By
CC       similarity). {ECO:0000250|UniProtKB:Q01097,
CC       ECO:0000250|UniProtKB:Q13224, ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27458189, ECO:0000269|PubMed:27916457,
CC       ECO:0000269|PubMed:28283559, ECO:0000269|PubMed:31080121}.
CC   -!- INTERACTION:
CC       Q00960; P11275: Camk2a; NbExp=2; IntAct=EBI-396905, EBI-2640645;
CC       Q00960; Q62936: Dlg3; NbExp=6; IntAct=EBI-396905, EBI-349596;
CC       Q00960; P31016: Dlg4; NbExp=8; IntAct=EBI-396905, EBI-375655;
CC       Q00960; P35439: Grin1; NbExp=13; IntAct=EBI-396905, EBI-877897;
CC       Q00960; P35439-7: Grin1; NbExp=2; IntAct=EBI-396905, EBI-15932497;
CC       Q00960; Q460M5: Lrfn2; NbExp=2; IntAct=EBI-396905, EBI-877185;
CC       Q00960; P11798: Camk2a; Xeno; NbExp=4; IntAct=EBI-396905, EBI-400384;
CC       Q00960; A0A1L8F5J9-8: grin1; Xeno; NbExp=6; IntAct=EBI-396905, EBI-16582829;
CC       Q00960; Q8R4I7: Neto1; Xeno; NbExp=2; IntAct=EBI-396905, EBI-2314926;
CC       Q00960; Q63ZW7: Patj; Xeno; NbExp=4; IntAct=EBI-396905, EBI-8366894;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1350383,
CC       ECO:0000269|PubMed:19910922, ECO:0000269|PubMed:21677647,
CC       ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925,
CC       ECO:0000269|PubMed:27916457}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925}.
CC       Postsynaptic cell membrane {ECO:0000269|PubMed:7513428,
CC       ECO:0000269|PubMed:9509416}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24876489, ECO:0000269|PubMed:27135925}. Late
CC       endosome {ECO:0000250|UniProtKB:Q01097}. Lysosome
CC       {ECO:0000250|UniProtKB:Q01097}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q01097}. Note=Co-localizes with the motor
CC       protein KIF17 along microtubules. {ECO:0000250|UniProtKB:Q01097}.
CC   -!- TISSUE SPECIFICITY: Expressed in the hippocampus including the dentate
CC       gyrus (at protein level) (PubMed:22960932). Detected in adult olfactory
CC       bulb, brain cortex, hippocampus, striatum, thalamus, superior
CC       colliculus, with much lower levels in inferior colliculus, midbrain and
CC       cerebellum. {ECO:0000269|PubMed:22960932, ECO:0000269|PubMed:9509416}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during postnatal days P3 to P60, with
CC       decreased expression after postnatal day 14.
CC       {ECO:0000269|PubMed:22960932}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of a
CC       transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000305|PubMed:24876489}.
CC   -!- PTM: Phosphorylated on tyrosine residues (PubMed:7513428).
CC       Phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor
CC       channel activity (By similarity). {ECO:0000250|UniProtKB:Q01097,
CC       ECO:0000269|PubMed:7513428}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. NR2B/GRIN2B subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M91562; AAA41714.1; -; mRNA.
DR   EMBL; U11419; AAA50554.1; -; mRNA.
DR   PIR; B43274; B43274.
DR   RefSeq; NP_036706.1; NM_012574.1.
DR   PDB; 3JPW; X-ray; 2.80 A; A=32-394.
DR   PDB; 3JPY; X-ray; 3.21 A; A=32-394.
DR   PDB; 3QEL; X-ray; 2.60 A; B/D=31-394.
DR   PDB; 3QEM; X-ray; 3.00 A; B/D=31-394.
DR   PDB; 4PE5; X-ray; 3.96 A; B/D=27-852.
DR   PDB; 5B3J; X-ray; 2.90 A; C/D=31-394.
DR   PDB; 5FXG; EM; 6.80 A; B/D=27-852.
DR   PDB; 5FXH; EM; 6.10 A; B/D=27-852.
DR   PDB; 5FXI; EM; 6.40 A; B/D=27-852.
DR   PDB; 5FXJ; EM; 6.50 A; B/D=27-852.
DR   PDB; 5FXK; EM; 6.40 A; B/D=27-852.
DR   PDB; 5TPZ; X-ray; 3.10 A; D=32-393.
DR   PDB; 6CNA; EM; 4.60 A; B/D=34-843.
DR   PDB; 6E7R; X-ray; 2.10 A; B/D=32-394.
DR   PDB; 6E7S; X-ray; 2.72 A; B/D=32-394.
DR   PDB; 6E7T; X-ray; 2.31 A; B/D=32-393.
DR   PDB; 6E7U; X-ray; 2.27 A; B/D=32-394.
DR   PDB; 6E7V; X-ray; 2.60 A; B/D=32-394.
DR   PDB; 6E7W; X-ray; 2.67 A; B/D=32-394.
DR   PDB; 6E7X; X-ray; 2.58 A; B/D=32-394.
DR   PDB; 6WHR; EM; 3.99 A; B/D=27-852.
DR   PDB; 6WHS; EM; 4.00 A; B/D=27-852.
DR   PDB; 6WHT; EM; 4.39 A; B/D=27-852.
DR   PDB; 6WHU; EM; 3.93 A; B/D=27-852.
DR   PDB; 6WHV; EM; 4.05 A; B/D=27-852.
DR   PDB; 6WHW; EM; 4.09 A; B/D=25-852.
DR   PDB; 6WHX; EM; 4.09 A; B/D=25-852.
DR   PDB; 6WHY; EM; 4.03 A; B/D=25-852.
DR   PDB; 6WI0; EM; 4.27 A; B/D=27-852.
DR   PDB; 6WI1; EM; 3.62 A; B/D=25-852.
DR   PDB; 7SAA; EM; 2.97 A; B/D=27-852.
DR   PDB; 7SAB; EM; 4.30 A; B/D=27-852.
DR   PDB; 7SAC; EM; 3.69 A; B/D=27-852.
DR   PDB; 7SAD; EM; 3.96 A; B/D=27-852.
DR   PDB; 7TE6; X-ray; 4.55 A; B/F=31-394.
DR   PDB; 7TE9; EM; 3.92 A; B/D=31-852.
DR   PDB; 7TEB; EM; 4.23 A; B/D=27-852.
DR   PDB; 7TEE; EM; 6.59 A; B/D=27-852.
DR   PDB; 7TEQ; EM; 7.51 A; B/D=27-852.
DR   PDB; 7TER; EM; 5.23 A; B/D=27-852.
DR   PDB; 7TES; EM; 4.70 A; B/D=27-852.
DR   PDB; 7TET; EM; 4.45 A; B/D=27-852.
DR   PDB; 8G18; X-ray; 2.85 A; B/D=32-394.
DR   PDBsum; 3JPW; -.
DR   PDBsum; 3JPY; -.
DR   PDBsum; 3QEL; -.
DR   PDBsum; 3QEM; -.
DR   PDBsum; 4PE5; -.
DR   PDBsum; 5B3J; -.
DR   PDBsum; 5FXG; -.
DR   PDBsum; 5FXH; -.
DR   PDBsum; 5FXI; -.
DR   PDBsum; 5FXJ; -.
DR   PDBsum; 5FXK; -.
DR   PDBsum; 5TPZ; -.
DR   PDBsum; 6CNA; -.
DR   PDBsum; 6E7R; -.
DR   PDBsum; 6E7S; -.
DR   PDBsum; 6E7T; -.
DR   PDBsum; 6E7U; -.
DR   PDBsum; 6E7V; -.
DR   PDBsum; 6E7W; -.
DR   PDBsum; 6E7X; -.
DR   PDBsum; 6WHR; -.
DR   PDBsum; 6WHS; -.
DR   PDBsum; 6WHT; -.
DR   PDBsum; 6WHU; -.
DR   PDBsum; 6WHV; -.
DR   PDBsum; 6WHW; -.
DR   PDBsum; 6WHX; -.
DR   PDBsum; 6WHY; -.
DR   PDBsum; 6WI0; -.
DR   PDBsum; 6WI1; -.
DR   PDBsum; 7SAA; -.
DR   PDBsum; 7SAB; -.
DR   PDBsum; 7SAC; -.
DR   PDBsum; 7SAD; -.
DR   PDBsum; 7TE6; -.
DR   PDBsum; 7TE9; -.
DR   PDBsum; 7TEB; -.
DR   PDBsum; 7TEE; -.
DR   PDBsum; 7TEQ; -.
DR   PDBsum; 7TER; -.
DR   PDBsum; 7TES; -.
DR   PDBsum; 7TET; -.
DR   PDBsum; 8G18; -.
DR   AlphaFoldDB; Q00960; -.
DR   EMDB; EMD-21673; -.
DR   EMDB; EMD-21674; -.
DR   EMDB; EMD-21675; -.
DR   EMDB; EMD-21676; -.
DR   EMDB; EMD-21677; -.
DR   EMDB; EMD-21678; -.
DR   EMDB; EMD-21679; -.
DR   EMDB; EMD-21680; -.
DR   EMDB; EMD-21681; -.
DR   EMDB; EMD-21682; -.
DR   EMDB; EMD-24946; -.
DR   EMDB; EMD-24947; -.
DR   EMDB; EMD-24948; -.
DR   EMDB; EMD-24949; -.
DR   EMDB; EMD-25843; -.
DR   EMDB; EMD-25844; -.
DR   EMDB; EMD-25845; -.
DR   EMDB; EMD-25849; -.
DR   EMDB; EMD-25850; -.
DR   EMDB; EMD-25851; -.
DR   EMDB; EMD-25852; -.
DR   EMDB; EMD-3352; -.
DR   EMDB; EMD-3353; -.
DR   EMDB; EMD-3354; -.
DR   EMDB; EMD-3355; -.
DR   EMDB; EMD-3356; -.
DR   EMDB; EMD-7529; -.
DR   SMR; Q00960; -.
DR   BioGRID; 246575; 24.
DR   ComplexPortal; CPX-284; NMDA receptor complex, GluN1-GluN2B.
DR   ComplexPortal; CPX-295; NMDA receptor complex, GluN1-GluN2A-GluN2B.
DR   CORUM; Q00960; -.
DR   DIP; DIP-33702N; -.
DR   IntAct; Q00960; 20.
DR   MINT; Q00960; -.
DR   STRING; 10116.ENSRNOP00000011697; -.
DR   BindingDB; Q00960; -.
DR   ChEMBL; CHEMBL311; -.
DR   DrugCentral; Q00960; -.
DR   GuidetoPHARMACOLOGY; 457; -.
DR   TCDB; 1.A.10.1.6; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   GlyCosmos; Q00960; 7 sites, 11 glycans.
DR   GlyGen; Q00960; 7 sites, 12 N-linked glycans (4 sites).
DR   iPTMnet; Q00960; -.
DR   PhosphoSitePlus; Q00960; -.
DR   SwissPalm; Q00960; -.
DR   PaxDb; 10116-ENSRNOP00000011697; -.
DR   ABCD; Q00960; 6 sequenced antibodies.
DR   GeneID; 24410; -.
DR   KEGG; rno:24410; -.
DR   UCSC; RGD:2738; rat.
DR   AGR; RGD:2738; -.
DR   CTD; 2904; -.
DR   RGD; 2738; Grin2b.
DR   eggNOG; KOG1053; Eukaryota.
DR   InParanoid; Q00960; -.
DR   OrthoDB; 1034721at2759; -.
DR   PhylomeDB; Q00960; -.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   Reactome; R-RNO-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   EvolutionaryTrace; Q00960; -.
DR   PRO; PR:Q00960; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:ARUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0044307; C:dendritic branch; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IDA:SynGO.
DR   GO; GO:0005770; C:late endosome; ISS:UniProtKB.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0043083; C:synaptic cleft; IDA:RGD.
DR   GO; GO:0097060; C:synaptic membrane; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0030018; C:Z disc; IDA:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:RGD.
DR   GO; GO:0005262; F:calcium channel activity; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:RGD.
DR   GO; GO:0031749; F:D2 dopamine receptor binding; IPI:RGD.
DR   GO; GO:0005234; F:extracellularly glutamate-gated ion channel activity; IDA:RGD.
DR   GO; GO:0016595; F:glutamate binding; IDA:UniProtKB.
DR   GO; GO:0035254; F:glutamate receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:glutamate-gated receptor activity; IDA:RGD.
DR   GO; GO:0016594; F:glycine binding; ISO:RGD.
DR   GO; GO:1901363; F:heterocyclic compound binding; IDA:RGD.
DR   GO; GO:0005149; F:interleukin-1 receptor binding; IPI:RGD.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; ISO:RGD.
DR   GO; GO:0005261; F:monoatomic cation channel activity; ISO:RGD.
DR   GO; GO:0099583; F:neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration; IMP:SynGO.
DR   GO; GO:0099529; F:neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IDA:UniProtKB.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0036094; F:small molecule binding; IPI:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; IMP:RGD.
DR   GO; GO:0008306; P:associative learning; IMP:RGD.
DR   GO; GO:0001662; P:behavioral fear response; IMP:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISS:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEP:RGD.
DR   GO; GO:0071386; P:cellular response to corticosterone stimulus; IEP:RGD.
DR   GO; GO:1904644; P:cellular response to curcumin; IEP:RGD.
DR   GO; GO:0071359; P:cellular response to dsRNA; IEP:RGD.
DR   GO; GO:1904322; P:cellular response to forskolin; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071396; P:cellular response to lipid; IEP:RGD.
DR   GO; GO:0010350; P:cellular response to magnesium starvation; IEP:RGD.
DR   GO; GO:0071287; P:cellular response to manganese ion; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0042596; P:fear response; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; IMP:RGD.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007612; P:learning; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:ARUK-UCL.
DR   GO; GO:0007616; P:long-term memory; IEP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEP:RGD.
DR   GO; GO:0007613; P:memory; IDA:UniProtKB.
DR   GO; GO:0098655; P:monoatomic cation transmembrane transport; ISS:ComplexPortal.
DR   GO; GO:0006812; P:monoatomic cation transport; ISO:RGD.
DR   GO; GO:0033555; P:multicellular organismal response to stress; IEP:RGD.
DR   GO; GO:1902951; P:negative regulation of dendritic spine maintenance; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; IEP:RGD.
DR   GO; GO:0098989; P:NMDA selective glutamate receptor signaling pathway; IMP:SynGO.
DR   GO; GO:2001056; P:positive regulation of cysteine-type endopeptidase activity; IGI:ARUK-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IDA:ComplexPortal.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IDA:UniProtKB.
DR   GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; IMP:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IDA:ComplexPortal.
DR   GO; GO:0051290; P:protein heterotetramerization; IDA:UniProtKB.
DR   GO; GO:0043113; P:receptor clustering; IDA:RGD.
DR   GO; GO:0032012; P:regulation of ARF protein signal transduction; IGI:RGD.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IMP:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IMP:UniProtKB.
DR   GO; GO:1904062; P:regulation of monoatomic cation transmembrane transport; ISS:ComplexPortal.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; NAS:ComplexPortal.
DR   GO; GO:0099566; P:regulation of postsynaptic cytosolic calcium ion concentration; IMP:SynGO.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0010738; P:regulation of protein kinase A signaling; ISO:RGD.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IEP:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IEP:RGD.
DR   GO; GO:0042220; P:response to cocaine; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0060416; P:response to growth hormone; IEP:RGD.
DR   GO; GO:1904880; P:response to hydrogen sulfide; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:0010042; P:response to manganese ion; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0051597; P:response to methylmercury; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0051707; P:response to other organism; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IDA:RGD.
DR   GO; GO:0046960; P:sensitization; IMP:RGD.
DR   GO; GO:0007423; P:sensory organ development; ISO:RGD.
DR   GO; GO:0001964; P:startle response; ISO:RGD.
DR   GO; GO:0001967; P:suckling behavior; ISO:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IBA:GO_Central.
DR   CDD; cd06378; PBP1_iGluR_NMDA_NR2; 1.
DR   CDD; cd13718; PBP2_iGluR_NMDA_Nr2; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 3.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF382; GLUTAMATE RECEPTOR IONOTROPIC, NMDA 2B; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disulfide bond; Endosome; Glycoprotein;
KW   Ion channel; Ion transport; Ligand-gated ion channel; Lysosome; Magnesium;
KW   Membrane; Metal-binding; Phosphoprotein; Postsynaptic cell membrane;
KW   Receptor; Reference proteome; Signal; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Zinc.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..1482
FT                   /note="Glutamate receptor ionotropic, NMDA 2B"
FT                   /id="PRO_0000011579"
FT   TOPO_DOM        27..557
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TRANSMEM        558..576
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TOPO_DOM        577..603
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   INTRAMEM        604..623
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000305|PubMed:24876489"
FT   TOPO_DOM        624..630
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TRANSMEM        631..646
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TOPO_DOM        647..817
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TRANSMEM        818..837
FT                   /note="Helical"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   TOPO_DOM        838..1482
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24876489"
FT   REGION          604..623
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0000305|PubMed:24876489"
FT   REGION          1161..1194
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1269..1301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1292..1304
FT                   /note="Interaction with DAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOTIF           1480..1482
FT                   /note="PDZ-binding"
FT   COMPBIAS        1269..1291
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         127
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:19910922,
FT                   ECO:0007744|PDB:3JPY"
FT   BINDING         284
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000305|PubMed:19910922,
FT                   ECO:0007744|PDB:3JPY"
FT   BINDING         514
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   BINDING         519
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   BINDING         690..691
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0007744|PDB:4PE5"
FT   BINDING         732
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   SITE            615
FT                   /note="Functional determinant of NMDA receptors"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         882
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         886
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         917
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         920
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         962
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1039
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1058
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1061
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1109
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1133
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1155
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   MOD_RES         1255
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1472
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01097"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19910922,
FT                   ECO:0000269|PubMed:24876489, ECO:0007744|PDB:3JPW,
FT                   ECO:0007744|PDB:3JPY, ECO:0007744|PDB:3QEL,
FT                   ECO:0007744|PDB:3QEM, ECO:0007744|PDB:4PE5"
FT   CARBOHYD        341
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19910922,
FT                   ECO:0000269|PubMed:24876489, ECO:0007744|PDB:3JPW,
FT                   ECO:0007744|PDB:3JPY, ECO:0007744|PDB:3QEL,
FT                   ECO:0007744|PDB:3QEM, ECO:0007744|PDB:4PE5,
FT                   ECO:0007744|PDB:5TPZ"
FT   CARBOHYD        348
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        444
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        491
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        542
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        688
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   DISULFID        86..321
FT                   /evidence="ECO:0000269|PubMed:19910922,
FT                   ECO:0007744|PDB:3JPW, ECO:0007744|PDB:3JPY,
FT                   ECO:0007744|PDB:3QEL, ECO:0007744|PDB:3QEM,
FT                   ECO:0007744|PDB:4PE5, ECO:0007744|PDB:5B3J,
FT                   ECO:0007744|PDB:5TPZ"
FT   DISULFID        429..456
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   DISULFID        436..457
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   DISULFID        746..801
FT                   /evidence="ECO:0000269|PubMed:24876489,
FT                   ECO:0007744|PDB:4PE5"
FT   MUTAGEN         60
FT                   /note="H->A: Normal zinc binding."
FT                   /evidence="ECO:0000269|PubMed:19910922"
FT   MUTAGEN         127
FT                   /note="H->A: Reduced zinc binding."
FT                   /evidence="ECO:0000269|PubMed:19910922"
FT   MUTAGEN         283
FT                   /note="D->A: Slightly reduced zinc binding."
FT                   /evidence="ECO:0000269|PubMed:19910922"
FT   MUTAGEN         284
FT                   /note="E->A: Reduced zinc binding."
FT                   /evidence="ECO:0000269|PubMed:19910922"
FT   MUTAGEN         311
FT                   /note="H->A: Normal zinc binding."
FT                   /evidence="ECO:0000269|PubMed:19910922"
FT   MUTAGEN         359
FT                   /note="H->A: Normal zinc binding."
FT                   /evidence="ECO:0000269|PubMed:19910922"
FT   MUTAGEN         1413
FT                   /note="S->L: Decreased localization to the cell membrane.
FT                   Decreased interaction with DLG3 and DLG4. No effect on
FT                   glutamate-gated calcium ion channel activity."
FT                   /evidence="ECO:0000269|PubMed:28283559"
FT   MUTAGEN         1422
FT                   /note="L->F: No effect on localizationto the cell membrane.
FT                   Decreased interaction with DLG3 and DLG4. No effect on
FT                   glutamate-gated calcium ion channel activity."
FT                   /evidence="ECO:0000269|PubMed:28283559"
FT   MUTAGEN         1450
FT                   /note="S->F: No effect on localizationto the cell membrane.
FT                   Decreased interaction with DLG3 and DLG4. No effect on
FT                   glutamate-gated calcium ion channel activity."
FT                   /evidence="ECO:0000269|PubMed:28283559"
FT   CONFLICT        1256
FT                   /note="E -> K (in Ref. 2; AAA50554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1430..1431
FT                   /note="VT -> SA (in Ref. 2; AAA50554)"
FT                   /evidence="ECO:0000305"
FT   STRAND          34..44
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           47..53
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           54..59
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          62..73
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           78..91
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          94..103
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           107..119
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           128..131
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          143..147
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           150..163
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          168..173
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           179..191
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          198..204
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          211..213
FT                   /evidence="ECO:0007829|PDB:3QEL"
FT   HELIX           215..220
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          226..232
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           234..246
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   TURN            248..250
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          251..253
FT                   /evidence="ECO:0007829|PDB:5B3J"
FT   STRAND          255..258
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           260..263
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:5TPZ"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:5TPZ"
FT   STRAND          278..281
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          283..287
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           289..311
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   TURN            322..325
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           326..330
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   HELIX           336..339
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          343..346
FT                   /evidence="ECO:0007829|PDB:8G18"
FT   STRAND          355..359
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          362..367
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          369..371
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          373..380
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          383..387
FT                   /evidence="ECO:0007829|PDB:6E7R"
FT   STRAND          405..410
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            414..416
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          417..421
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            424..426
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          434..439
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          444..446
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          452..459
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           460..472
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          475..480
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          483..486
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           496..502
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          504..506
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           518..521
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          523..525
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          529..532
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          534..539
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   TURN            547..551
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          552..554
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           556..578
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           603..613
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           626..655
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           669..672
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          674..679
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          687..689
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           690..698
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           700..705
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           706..709
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           714..722
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          727..732
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           733..740
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          744..746
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          748..750
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           751..753
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   STRAND          760..762
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           772..785
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           788..796
FT                   /evidence="ECO:0007829|PDB:7SAA"
FT   HELIX           815..844
FT                   /evidence="ECO:0007829|PDB:7SAA"
SQ   SEQUENCE   1482 AA;  166071 MW;  AEF8B9DF3C1B0D5D CRC64;
     MKPSAECCSP KFWLVLAVLA VSGSKARSQK SPPSIGIAVI LVGTSDEVAI KDAHEKDDFH
     HLSVVPRVEL VAMNETDPKS IITRICDLMS DRKIQGVVFA DDTDQEAIAQ ILDFISAQTL
     TPILGIHGGS SMIMADKDES SMFFQFGPSI EQQASVMLNI MEEYDWYIFS IVTTYFPGYQ
     DFVNKIRSTI ENSFVGWELE EVLLLDMSLD DGDSKIQNQL KKLQSPIILL YCTKEEATYI
     FEVANSVGLT GYGYTWIVPS LVAGDTDTVP SEFPTGLISV SYDEWDYGLP ARVRDGIAII
     TTAASDMLSE HSFIPEPKSS CYNTHEKRIY QSNMLNRYLI NVTFEGRNLS FSEDGYQMHP
     KLVIILLNKE RKWERVGKWK DKSLQMKYYV WPRMCPETEE QEDDHLSIVT LEEAPFVIVE
     SVDPLSGTCM RNTVPCQKRI ISENKTDEEP GYIKKCCKGF CIDILKKISK SVKFTYDLYL
     VTNGKHGKKI NGTWNGMIGE VVMKRAYMAV GSLTINEERS EVVDFSVPFI ETGISVMVSR
     SNGTVSPSAF LEPFSADVWV MMFVMLLIVS AVAVFVFEYF SPVGYNRCLA DGREPGGPSF
     TIGKAIWLLW GLVFNNSVPV QNPKGTTSKI MVSVWAFFAV IFLASYTANL AAFMIQEEYV
     DQVSGLSDKK FQRPNDFSPP FRFGTVPNGS TERNIRNNYA EMHAYMGKFN QRGVDDALLS
     LKTGKLDAFI YDAAVLNYMA GRDEGCKLVT IGSGKVFAST GYGIAIQKDS GWKRQVDLAI
     LQLFGDGEME ELEALWLTGI CHNEKNEVMS SQLDIDNMAG VFYMLGAAMA LSLITFICEH
     LFYWQFRHCF MGVCSGKPGM VFSISRGIYS CIHGVAIEER QSVMNSPTAT MNNTHSNILR
     LLRTAKNMAN LSGVNGSPQS ALDFIRRESS VYDISEHRRS FTHSDCKSYN NPPCEENLFS
     DYISEVERTF GNLQLKDSNV YQDHYHHHHR PHSIGSTSSI DGLYDCDNPP FTTQPRSISK
     KPLDIGLPSS KHSQLSDLYG KFSFKSDRYS GHDDLIRSDV SDISTHTVTY GNIEGNAAKR
     RKQQYKDSLK KRPASAKSRR EFDEIELAYR RRPPRSPDHK RYFRDKEGLR DFYLDQFRTK
     ENSPHWEHVD LTDIYKERSD DFKRDSVSGG GPCTNRSHLK HGTGEKHGVV GGVPAPWEKN
     LTNVDWEDRS GGNFCRSCPS KLHNYSSTVA GQNSGRQACI RCEACKKAGN LYDISEDNSL
     QELDQPAAPV AVTSNASSTK YPQSPTNSKA QKKNRNKLRR QHSYDTFVDL QKEEAALAPR
     SVSLKDKGRF MDGSPYAHMF EMPAGESSFA NKSSVPTAGH HHNNPGSGYM LSKSLYPDRV
     TQNPFIPTFG DDQCLLHGSK SYFFRQPTVA GASKTRPDFR ALVTNKPVVV TLHGAVPGRF
     QKDICIGNQS NPCVPNNKNP RAFNGSSNGH VYEKLSSIES DV
//
